Combined Phycocyanin and Hematoporphyrin Monomethyl Ether for Breast Cancer Treatment via Photosensitizers Modified Fe3O4Nanoparticles Inhibiting the Proliferation and Migration of MCF-7 Cells

Authors:

Abstract
Photodynamic therapy (PDT), combining the laser and photosensitizers to kill tumor cells, has the potential to address many currently medical requirements. In this study, magnetic Fe3O4 nanoparticles were firstly employed as cores, and modified with oleic acid (OA) and 3-triethoxysilyl-1-Propanamine. Then, the photosensitizers phycocyanin (PC) and hematoporphyrin monomethyl ether (HMME), which might be able to stimulate the cell release of ROS after the irradiation of near infrared (NIR) laser, were grafted on the surface of such nanoparticles. Our results revealed the high-efficiency inhibition of breast cancer MCF-7 cells growing upon near-infrared irradiation both in vitro and in vivo. Furthermore, it was the synergy between the natural photosensitizers PC and the synthetic photosensitizers HMME that deeply influenced such inhibition, comparing to the groups that used either of these medicines alone. To utilize the combination of different photosensitive agents, our study thus provides a new strategy for breast cancer treatment.
Funding Information
  • National Natural Science Foundation of China (31170919, 31370967, 81371646)
  • Guangdong Province (2015A020212033)

This publication has 52 references indexed in Scilit: